Regulus Therapeutics Inc (NASDAQ:RGLS)

12.85
Delayed Data
As of May 22
 +0.10 / +0.78%
Today’s Change
6.08
Today|||52-Week Range
25.60
-19.89%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues736.0K1.1M4.2M4.2M
 
 
 
 
 
Depreciation And Amortization346.0K398.0K392.0K--
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses13.4M12.3M13.4M17.1M
 
 
 
 
 
Research And Development10.8M10.2M10.5M13.4M
 
 
 
 
 
Total Operating Expenses13.7M12.7M13.8M17.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-13.0M-11.7M-9.5M-12.9M
 
 
 
 
 
Extraordinary Credit953.0K1.8M----
 
 
 
Extraordinary Charge0.00---12.7M--
 
 
Interest Expense On Debt10.0K10.0K8.0K--
 
 
 
 
Other Expenses0.000.000.00-1.6M
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-12.0M-9.8M-22.2M-14.5M
 
 
 
 
 
Income Taxes0.000.000.00-4.0K
 
 
Net Income-12.0M-9.8M-22.2M-14.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS43.4M43.4M46.9M50.1M
 
 
 
 
 
Shares To Calculate EPS Diluted44.8M43.4M46.9M50.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.29-$0.23-$0.47-$0.29
 
 
 
 
 
EPS Diluted-$0.29-$0.23-$0.47-$0.29
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account